Talc Baby Powder Lawsuit | June 2025 Settlement Update A Texas bankruptcy judge has temporarily halted some talc lawsuits against Johnson Johnson to address jurisdictional questions in the Chapter 11 case of its spinoff, Red River Talc LLC Red River was created to handle these claims, offering a $9 billion settlement plan to victims
Talcum Powder Lawsuit (June Update) | Oberheiden P. C. May 23, 2025 – According to Environmental Health News, a new book allegedly, “reveals how Johnson Johnson knowingly sold talc-based baby powder contaminated with asbestos, triggering thousands of cancer cases while burying evidence and manipulating science ”
Johnson Johnson Announces that its Subsidiary, Red River . . . The Plan enables a full and final resolution of the Company’s ovarian talc litigation The Plan would resolve 99 75% of all pending talc lawsuits against Johnson Johnson and its affiliates in the United States
Talcum Powder Settlement | $8. 2Billion Johnson Johnson Offer Here is a summary of developments on the latest talcum powder lawsuits against Johnson Johnson: March 2025: A Houston judge has dismissed Red River Talc's bankruptcy case, bringing an end to J J's multibillion-dollar settlement attempt
Judge to Decide J J’s $8. 2B Talc Settlement Offer in 2025 A high-stakes trial is ahead for Johnson Johnson in January 2025 A federal judge in Houston will decide on the company’s $8 2 billion settlement offer If approved, it will end thousands of cancer lawsuits linked to J J’s baby powder
J J unit files for Chapter 11 to advance $8bn talc settlement In a bid to end tens of thousands of lawsuits alleging baby powder and other talc products caused cancer, a subsidiary of healthcare giant Jonson Johnson (J J) has filed for Chapter 11 Red River Talc LLC, a unit of J J, made the filing after it received the support of the overwhelming majority – approximately 83 percent – of current
Johnson Johnson Faces Multibillion-Dollar Settlement as . . . The company unveiled a prepackaged plan supported by 83% of the current talc injury plaintiffs, setting the groundwork for an $8 billion settlement fund intended to cover both existing and future claims of ovarian cancer linked to its talc products